Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome

Gastroenterology

Volumn 152, Issue 1, 2017, Pages 111-123.e8

  Tap, Julien ^a,b   Derrien, Muriel ^a   Törnblom, Hans ^c   Brazeilles, Rémi ^a   Cools Portier, Stéphanie ^a   Doré, Joël ^b   Störsrud, Stine ^c   Le Nevé, Boris ^a   Öhman, Lena ^c,d   Simrén, Magnus ^c,e  

^a Groupe Danone   (France)

^b University of Paris Saclay   (France)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d UNIVERSITY OF SKÖVDE   (Sweden)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Bacteria; Functional Bowel Disorder; Microbiome

Indexed keywords

ANTACID AGENT; ANTIDEPRESSANT AGENT; ANTIDIARRHEAL AGENT; BULKING AGENT; LAXATIVE; RNA 16S; BACTERIAL DNA; HYDROGEN; METHANE;

ADULT; ARTICLE; BACTERIUM IDENTIFICATION; BACTEROIDACEAE; BACTEROIDETES; BLAUTIA; BODY MASS; CLINICAL FEATURE; CLOSTRIDIALES; CONSTIPATION; CONTROLLED STUDY; DEFECATION HABIT; DIARRHEA; DIET; DIGESTIVE SYSTEM DISEASE ASSESSMENT; DISEASE CLASSIFICATION; DISEASE SEVERITY ASSESSMENT; DNA EXTRACTION; FECES MICROFLORA; FEMALE; FIRMICUTES; GASTROENTEROLOGIST; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TRANSIT; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INTESTINE FLORA; IRRITABLE COLON; LACHNOSPIRACEAE; MAJOR CLINICAL STUDY; MALE; METHANOBACTERIALES; METHANOGEN; POLYMERASE CHAIN REACTION; PREVOTELLA; PRIORITY JOURNAL; PYROSEQUENCING; QUESTIONNAIRE; RUMINOCOCCACEAE; BACTEROIDES; BREATH ANALYSIS; CASE CONTROL STUDY; FECES; INTESTINE MUCOSA; ISOLATION AND PURIFICATION; MACHINE LEARNING; MICROBIOLOGY; MICROFLORA; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; VALIDATION STUDY; YOUNG ADULT;

ADULT; BACTEROIDES; BREATH TESTS; CASE-CONTROL STUDIES; CLOSTRIDIALES; DNA, BACTERIAL; FECES; FEMALE; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRANSIT; HUMANS; HYDROGEN; INTESTINAL MUCOSA; IRRITABLE BOWEL SYNDROME; MACHINE LEARNING; MALE; METHANE; METHANOBACTERIALES; MICROBIOTA; PREVOTELLA; PROSPECTIVE STUDIES; RNA, RIBOSOMAL, 16S; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 85006287897     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2016.09.049     Document Type: Article

References (63)

1. 1 Almquist, E., Törnblom, H., Simrén, M., Practical management of irritable bowel syndrome: a clinical review. Minerva Gastroenterol Dietol 62 (2016), 30–48.
2. 2 Sood, R., Law, G.R., Ford, A.C., Diagnosis of IBS: symptoms, symptom-based criteria, biomarkers or “psychomarkers”?. Nat Rev Gastroenterol Hepatol 11 (2014), 683–691.
3. 3 Rajilić-Stojanović, M., Jonkers, D.M., Salonen, A., et al. Intestinal microbiota and diet in IBS: causes, consequences, or epiphenomena?. Am J Gastroenterol 110 (2015), 278–287.
4. 4 Ohman, L., Simrén, M., Intestinal microbiota and its role in irritable bowel syndrome (IBS). Curr Gastroenterol Rep, 15, 2013, 323.
5. 5 Kassinen, A., Krogius-Kurikka, L., Mäkivuokko, H., et al. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 133 (2007), 24–33.
6. 6 Salonen, A., de Vos, W.M., Palva, A., Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectives. Microbiology 156 (2010), 3205–3215.
7. 7 Simrén, M., Barbara, G., Flint, H.J., et al. Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut 62 (2013), 159–176.
8. 8 Rajilić-Stojanović, M., Biagi, E., Heilig, H.G.H.J., et al. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 141 (2011), 1792–1801.
9. 9 Jeffery, I.B., O'Toole, P.W., Öhman, L., et al. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut 61 (2012), 997–1006.
10. 10 Durbán, A., Abellán, J.J., Jiménez-Hernández, N., et al. Instability of the faecal microbiota in diarrhoea-predominant irritable bowel syndrome. FEMS Microbiol Ecol 86 (2013), 581–589.
11. 11 Shankar, V., Homer, D., Rigsbee, L., et al. The networks of human gut microbe-metabolite associations are different between health and irritable bowel syndrome. ISME J 9 (2015), 1899–1903.
12. 12 Duboc, H., Rainteau, D., Rajca, S., et al. Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome. Neurogastroenterol Motil, 24, 2012 513–e247.
13. 13 Codling, C., O'Mahony, L., Shanahan, F., et al. A molecular analysis of fecal and mucosal bacterial communities in irritable bowel syndrome. Dig Dis Sci 55 (2010), 392–397.
14. 14 Ng, S.C., Lam, E.F.C., Lam, T.T.Y., et al. Effect of probiotic bacteria on the intestinal microbiota in irritable bowel syndrome. J Gastroenterol Hepatol 28 (2013), 1624–1631.
15. 15 Durbán, A., Abellán, J.J., Jiménez-Hernández, N., et al. Structural alterations of faecal and mucosa-associated bacterial communities in irritable bowel syndrome. Environ Microbiol Rep 4 (2012), 242–247.
16. 16 Rangel, I., Sundin, J., Fuentes, S., et al. The relationship between faecal-associated and mucosal-associated microbiota in irritable bowel syndrome patients and healthy subjects. Aliment Pharmacol Ther 42 (2015), 1211–1221.
17. 17 Harrell, L., Wang, Y., Antonopoulos, D., et al. Standard colonic lavage alters the natural state of mucosal-associated microbiota in the human colon. PloS One, 7, 2012, e32545.
18. 18 Longstreth, G.F., Thompson, W.G., Chey, W.D., et al. Functional bowel disorders. Gastroenterology 130 (2006), 1480–1491.
19. 19 Francis, C.Y., Morris, J., Whorwell, P.J., The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther 11 (1997), 395–402.
20. 20 Zigmond, A.S., Snaith, R.P., The hospital anxiety and depression scale. Acta Psychiatr Scand 67 (1983), 361–370.
21. 21 Böhn, L., Störsrud, S., Liljebo, T., et al. Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial. Gastroenterology 149 (2015), 1399–1407.e2.
22. 22 Heaton, K.W., O'Donnell, L.J., An office guide to whole-gut transit time. Patients’ recollection of their stool form. J Clin Gastroenterol 19 (1994), 28–30.
23. 23 Törnblom, H., Van Oudenhove, L., Sadik, R., et al. Colonic transit time and IBS symptoms: what's the link?. Am J Gastroenterol 107 (2012), 754–760.
24. 24 Matsuki, T., Watanabe, K., Fujimoto, J., et al. Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in human feces. Appl Environ Microbiol 70 (2004), 7220–7228.
25. 25 Godon, J.J., Zumstein, E., Dabert, P., et al. Molecular microbial diversity of an anaerobic digestor as determined by small-subunit rDNA sequence analysis. Appl Environ Microbiol 63 (1997), 2802–2813.
26. 26 Edgar, R.C., UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat Methods 10 (2013), 996–998.
27. 27 Yu, Y., Lee, C., Kim, J., et al. Group-specific primer and probe sets to detect methanogenic communities using quantitative real-time polymerase chain reaction. Biotechnol Bioeng 89 (2005), 670–679.
28. 28 Oksanen, J., Blanchet, F., Kindt, R., et al. Vegan: community ecology package. R package version 1.17-1, 2010. R Package Version, 2010, 1–17.
29. 29 Arumugam, M., Raes, J., Pelletier, E., et al. Enterotypes of the human gut microbiome. Nature 473 (2011), 174–180.
30. 30 Holmes, I., Harris, K., Quince, C., Dirichlet multinomial mixtures: generative models for microbial metagenomics. PloS One, 7, 2012, e30126.
31. 31 Tibshirani, R., Regression shrinkage and selection via the lasso: a retrospective. J R Stat Soc Ser B Stat Methodol 73 (2011), 273–282.
32. 32 Fan, R.-E., Chang, K.-W., Hsieh, C.-J., et al. LIBLINEAR: a library for large linear classification. J Mach Learn Res 9 (2008), 1871–1874.
33. 33 Zeller, G., Tap, J., Voigt, A.Y., et al. Potential of fecal microbiota for early-stage detection of colorectal cancer. Mol Syst Biol, 10, 2014, 766.
34. 34 Dray, S., Chessel, D., Thioulouse, J., Co-inertia analysis and the linking of ecological data tables. Ecology 84 (2003), 3078–3089.
35. 35 Tap, J., Furet, J.-P., Bensaada, M., et al. Gut microbiota richness promotes its stability upon increased dietary fibre intake in healthy adults. Environ Microbiol 17 (2015), 4954–4964.
36. 36 Benjamini, Y., Hochberg, Y., Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodol 57 (1995), 289–300.
37. 37 Dlugosz, A., Winckler, B., Lundin, E., et al. No difference in small bowel microbiota between patients with irritable bowel syndrome and healthy controls. Sci Rep, 5, 2015, 8508.
38. 38 Pozuelo, M., Panda, S., Santiago, A., et al. Reduction of butyrate- and methane-producing microorganisms in patients with irritable bowel syndrome. Sci Rep, 5, 2015, 12693.
39. 39 Ringel, Y., Maharshak, N., Ringel-Kulka, T., et al. High throughput sequencing reveals distinct microbial populations within the mucosal and luminal niches in healthy individuals. Gut Microbes 6 (2015), 173–181.
40. 40 Carroll, I.M., Ringel-Kulka, T., Keku, T.O., et al. Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 301 (2011), G799–G807.
41. 41 Yasuda, K., Oh, K., Ren, B., et al. Biogeography of the intestinal mucosal and lumenal microbiome in the rhesus macaque. Cell Host Microbe 17 (2015), 385–391.
42. 42 Chaudhary, P., Gaci, N., Borrel, G., et al. Molecular methods for studying methanogens of the human gastrointestinal tract: current status and future directions. Appl Microbiol Biotechnol 99 (2015), 5801–5815.
43. 43 Dridi, B., Henry, M., El Khéchine, A., et al. High prevalence of Methanobrevibacter smithii and Methanosphaera stadtmanae detected in the human gut using an improved DNA detection protocol. PLoS One, 4, 2009, e7063.
44. 44 Sahakian, A.B., Jee, S.-R., Pimentel, M., Methane and the gastrointestinal tract. Dig Dis Sci 55 (2010), 2135–2143.
45. 45 Kim, G., Deepinder, F., Morales, W., et al. Methanobrevibacter smithii is the predominant methanogen in patients with constipation-predominant IBS and methane on breath. Dig Dis Sci 57 (2012), 3213–3218.
46. 46 Vandeputte, D., Falony, G., Vieira-Silva, S., et al. Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates. Gut 65 (2016), 57–62.
47. 47 Falony, G., Joossens, M., Vieira-Silva, S., et al. Population-level analysis of gut microbiome variation. Science 352 (2016), 560–564.
48. 48 Knights, D., Costello, E.K., Knight, R., Supervised classification of human microbiota. FEMS Microbiol Rev 35 (2011), 343–359.
49. 49 Forslund, K., Hildebrand, F., Nielsen, T., et al. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 528 (2015), 262–266.
50. 50 Tap, J., Mondot, S., Levenez, F., et al. Towards the human intestinal microbiota phylogenetic core. Environ Microbiol 11 (2009), 2574–2584.
51. 51 Qin, J., Li, R., Raes, J., et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464 (2010), 59–65.
52. 52 Spanogiannopoulos, P., Bess, E.N., Carmody, R.N., et al. The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism. Nat Rev Microbiol 14 (2016), 273–287.
53. 1 Francis, C.Y., Morris, J., Whorwell, P.J., The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther 11 (1997), 395–402.
54. 2 Zigmond, A.S., Snaith, R.P., The hospital anxiety and depression scale. Acta Psychiatr Scand 67 (1983), 361–370.
55. 3 Heaton, K.W., O'Donnell, L.J., An office guide to whole-gut transit time. Patients’ recollection of their stool form. J Clin Gastroenterol 19 (1994), 28–30.
56. 4 Törnblom, H., Van Oudenhove, L., Sadik, R., et al. Colonic transit time and IBS symptoms: what's the link?. Am J Gastroenterol 107 (2012), 754–760.
57. 5 Godon, J.J., Zumstein, E., Dabert, P., et al. Molecular microbial diversity of an anaerobic digestor as determined by small-subunit rDNA sequence analysis. Appl Environ Microbiol 63 (1997), 2802–2813.
58. 6 Hildebrand, F., Tadeo, R., Voigt, A., et al. LotuS: an efficient and user-friendly OTU processing pipeline. Microbiome, 2, 2014, 30.
59. 7 Charif, D., Lobry, J., SeqinR 1.0-2: a contributed package to the R Project for statistical computing devoted to biological sequences retrieval and analysis. Bastolla, U., Porto, M., Roman, H.E., et al. (eds.) Structural approaches to sequence evolution. Biological and medical physics, biomedical engineering, 2007, Springer, Berlin, 207–232 Available at: http://dx.doi.org/10.1007/978-3-540-35306-5_10.
60. 8 Dray, S., Chessel, D., Thioulouse, J., Co-inertia analysis and the linking of ecological data tables. Ecology 84 (2003), 3078–3089.
61. 9 Tibshirani, R., Regression shrinkage and selection via the lasso: a retrospective. J R Stat Soc Ser B Stat Methodol 73 (2011), 273–282.
62. 10 Fan, R.-E., Chang, K.-W., Hsieh, C.-J., et al. LIBLINEAR: a library for large linear classification. J Mach Learn Res 9 (2008), 1871–1874.
63. 11 Zeller, G., Tap, J., Voigt, A.Y., et al. Potential of fecal microbiota for early-stage detection of colorectal cancer. Mol Syst Biol, 10, 2014, 766.